8-K: Celularity Extends Maturity Date of Convertible Promissory Note with YA II PN, Ltd.

Celularity Inc. extends the maturity date of its convertible promissory note with YA II PN, Ltd. in exchange for issuing restricted common stock.

Summary

• On May 20, 2025, Celularity Inc. entered into a letter agreement with YA II PN, Ltd. to extend the maturity date of a convertible promissory note.
• The original note was dated March 13, 2024.
• The maturity date was extended from May 12, 2025, to August 15, 2025.
• In exchange for the extension, Celularity issued 100,000 shares of restricted common stock to YA.
• These shares have piggyback registration rights, meaning their resale will be included in any registration statement filed by Celularity after the date of the agreement.

Sentiment

Score: 5

Explanation: The extension provides short-term relief but involves dilution, resulting in a neutral sentiment.

Positives

• Extending the maturity date of the convertible promissory note provides Celularity with additional time to manage its debt obligations.

Negatives

• Issuing 100,000 shares of restricted common stock to YA dilutes existing shareholders' equity.

Risks

• The issuance of restricted common stock could put downward pressure on the company's stock price.
• The company's ability to meet its debt obligations remains a concern.

Future Outlook

The company's future financial performance will depend on its ability to manage its debt and execute its business strategy.

Management Comments

• Robert J. Hariri, M.D., Ph.D., Chairman and CEO, signed the report on behalf of Celularity Inc.

Industry Context

Many biotech companies rely on convertible notes for financing, and extending maturity dates is a common practice to manage short-term debt obligations.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• The extension provides Celularity with more financial flexibility, which could benefit employees and other stakeholders.

Key Dates

Keywords

Convertible Promissory Note, Maturity Date Extension, Restricted Common Stock, YA II PN, Ltd., Celularity, Debt, Financing